Eleni Arvanitou
Overview
Explore the profile of Eleni Arvanitou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zouki D, Kardara V, Ioannou S, Arvanitou E, Exarchos K, Gkikas K, et al.
Clin Case Rep
. 2024 Jul;
12(7):e9180.
PMID: 39021492
Key Clinical Message: There is no consensus regarding the therapeutic approach of breast neuroendocrine carcinomas (NECs). As most NECs are hormone receptor positive and HER-2 negative, we suggest that endocrine-based...
2.
Galiti D, Linardou H, Agelaki S, Karampeazis A, Tsoukalas N, Psyrri A, et al.
Curr Oncol
. 2023 Aug;
30(8):7608-7619.
PMID: 37623032
Introduction: The increasing burden of cancer, the development of novel therapies, and the COVID-19 pandemic have made cancer care more complex. Digital innovation was then pushed toward developing platforms to...
3.
Arvanitou E, Nikoloudi M, Tsoukalas N, Parpa E, Mystakidou K
Psychooncology
. 2023 Feb;
32(5):712-720.
PMID: 36797821
Objective: Anxiety and depression are common in cancer patients and seem to affect quality of life, treatment compliance and even survival. Defining factors related to anxiety and depression and exploring...
4.
Fiste O, Tsiogka A, Arvanitou E, Karampeazis A, Christofyllakis C
Cureus
. 2020 Oct;
12(9):e10514.
PMID: 33094055
Sinonasal tumors arising from Schneiderian papillomas, most frequently associated with squamous cell carcinoma (SCC), are rare and often present with non-specific symptoms, even in an advanced stage. Herein, we report...